메뉴 건너뛰기




Volumn 5, Issue 15, 2014, Pages 6404-6413

Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm

(17)  Stenzinger, Albrecht a   Endris, Volker a   Pfarr, Nicole a   Andrulis, Mindaugas a   Korinna Johrens b   Klauschen, Frederick b   Siebolts, Udo c   Wolf, Thomas a   Koch, Philipp Sebastian d   Schulz, Miriam e   Hartschuh, Wolfgang a   Goerdt, Sergij d   Lennerz K , Jochen f,i   Wickenhauser, Claudia c   Klapper, Wolfram g   Anagnostopoulos, Ioannis b   Weichert, Wilko a,h  


Author keywords

ATM; Blastic plasmacytoid dendritic cell neoplasm; BPDCN; CDKN2A; KRAS; Mutually exclusive mutations; Next generation sequencing; NRAS; Recurrent mutations

Indexed keywords

APC PROTEIN; ATM PROTEIN; B RAF KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; ISOCITRATE DEHYDROGENASE 2; PROTEIN MLH1; PROTEIN RET; SCATTER FACTOR RECEPTOR; STEM CELL FACTOR RECEPTOR; VON HIPPEL LINDAU PROTEIN;

EID: 84906281985     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2223     Document Type: Article
Times cited : (83)

References (42)
  • 2
    • 84863040874 scopus 로고    scopus 로고
    • Blastic plasmacytoid dendritic cell neoplasm
    • Lee JK, Schiller G. Blastic plasmacytoid dendritic cell neoplasm. Clin Adv Hematol Oncol. 2012; 10: 60-2.
    • (2012) Clin Adv Hematol Oncol. , vol.10 , pp. 60-62
    • Lee, J.K.1    Schiller, G.2
  • 3
    • 84879409907 scopus 로고    scopus 로고
    • Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation
    • Kharfan-Dabaja MA, Lazarus HM, Nishihori T, Mahfouz RA, Hamadani M. Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2013; 19: 1006-12.
    • (2013) Biol Blood Marrow Transplant. , vol.19 , pp. 1006-1012
    • Kharfan-Dabaja, M.A.1    Lazarus, H.M.2    Nishihori, T.3    Mahfouz, R.A.4    Hamadani, M.5
  • 5
    • 79960262495 scopus 로고    scopus 로고
    • Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity
    • Dietrich S, Andrulis M, Hegenbart U, Schmitt T, Bellos F, Martens UM, Meissner J, Krämer A, Ho AD, Dreger P. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Biol Blood Marrow Transplant. 2011; A17:1250-4
    • (2011) Biol Blood Marrow Transplant , vol.A17 , pp. 1250-1254
    • Dietrich, S.1    Andrulis, M.2    Hegenbart, U.3    Schmitt, T.4    Bellos, F.5    Martens, U.M.6    Meissner, J.7    Krämer, A.8    Ho, A.D.9    Dreger, P.10
  • 8
    • 84872470209 scopus 로고    scopus 로고
    • European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation
    • Roos-Weil D, Dietrich S, Boumendil A, Polge E, Bron D, Carreras E, Iriondo Atienza A, Arcese W, Beelen DW, Cornelissen JJ, Kröger N, Milone G, Rossi G, Jardin F, Peters C, Rocha V, Sureda A, Mohty M, Dreger P; European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood. 2013; 17;121: 440-6.
    • (2013) Blood. , vol.17 , Issue.121 , pp. 440-446
    • Roos-Weil, D.1    Dietrich, S.2    Boumendil, A.3    Polge, E.4    Bron, D.5    Carreras, E.6    Iriondo Atienza, A.7    Arcese, W.8    Beelen, D.W.9    Cornelissen, J.J.10    Kröger, N.11    Milone, G.12    Rossi, G.13    Jardin, F.14    Peters, C.15    Rocha, V.16    Sureda, A.17    Mohty, M.18    Dreger, P.19
  • 9
    • 33846441606 scopus 로고    scopus 로고
    • Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
    • Garnache-Ottou F, Feuillard J, Saas P. Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity? Br J Haematol. 2007; 136: 539-548.
    • (2007) Br J Haematol. , vol.136 , pp. 539-548
    • Garnache-Ottou, F.1    Feuillard, J.2    Saas, P.3
  • 10
    • 34249732606 scopus 로고    scopus 로고
    • (2007) CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells
    • Herling M, Jones D. (2007) CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol. 2007; 127: 687-700.
    • (2007) Am J Clin Pathol. , vol.127 , pp. 687-700
    • Herling, M.1    Jones, D.2
  • 12
    • 59449096793 scopus 로고    scopus 로고
    • Blastic plasmacytoid dendritic cell neoplasms
    • WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues (Swerdlow SH, Campo E, Harris NL, eds) Lyon: IARC
    • Facchetti F JD, Petrella T. (2008) Blastic plasmacytoid dendritic cell neoplasms. In: WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues (Swerdlow SH, Campo E, Harris NL, et al eds) Lyon: IARC; 145-147.
    • (2008) , pp. 145-147
    • Facchetti, F.J.D.1    Petrella, T.2
  • 14
    • 73949122748 scopus 로고    scopus 로고
    • Plasmacytoid dendritic cells: physiologic roles and pathologic states
    • Jegalian AG, Facchetti F, Jaffe ES. Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol. 2009; 16: 392-404.
    • (2009) Adv Anat Pathol. , vol.16 , pp. 392-404
    • Jegalian, A.G.1    Facchetti, F.2    Jaffe, E.S.3
  • 15
    • 0036301139 scopus 로고    scopus 로고
    • (2002) 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes
    • Petrella T, Comeau MR, Maynadié M, Couillault G, De Muret A, Maliszewski CR, Dalac S, Durlach A, Galibert L. (2002) 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002; 26: 852-62.
    • (2002) Am J Surg Pathol. , vol.26 , pp. 852-862
    • Petrella, T.1    Comeau, M.R.2    Maynadié, M.3    Couillault, G.4    De Muret, A.5    Maliszewski, C.R.6    Dalac, S.7    Durlach, A.8    Galibert, L.9
  • 16
    • 28244492017 scopus 로고    scopus 로고
    • Plasmacytoid dendritic cells of different origins have distinct characteristics and function: studies of lymphoid progenitors versus myeloid progenitors
    • Yang GX, Lian ZX, Kikuchi K, Moritoki Y, Ansari AA, Liu YJ, Ikehara S, Gershwin ME. Plasmacytoid dendritic cells of different origins have distinct characteristics and function: studies of lymphoid progenitors versus myeloid progenitors. J Immunol. 2005; 175: 7281-7.
    • (2005) J Immunol. , vol.175 , pp. 7281-7287
    • Yang, G.X.1    Lian, Z.X.2    Kikuchi, K.3    Moritoki, Y.4    Ansari, A.A.5    Liu, Y.J.6    Ikehara, S.7    Gershwin, M.E.8
  • 21
    • 77949531452 scopus 로고    scopus 로고
    • Alterations of the cell cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms
    • Wiesner T, Obenauf AC, Cota C, Fried I, Speicher MR, Cerroni L. Alterations of the cell cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms. J Invest Dermatol. 2009; 130: 1152-1157.
    • (2009) J Invest Dermatol. , vol.130 , pp. 1152-1157
    • Wiesner, T.1    Obenauf, A.C.2    Cota, C.3    Fried, I.4    Speicher, M.R.5    Cerroni, L.6
  • 23
    • 84886052163 scopus 로고    scopus 로고
    • Molecular diagnostic profiling of lung cancer specimens with a semiconductorbased massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing
    • Endris V, Penzel R, Warth A, Muckenhuber A, Schirmacher P, Stenzinger A, Weichert W. Molecular diagnostic profiling of lung cancer specimens with a semiconductorbased massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing. J Mol Diagn. 2013; 15, 765-75.
    • (2013) J Mol Diagn , vol.15 , pp. 765-775
    • Endris, V.1    Penzel, R.2    Warth, A.3    Muckenhuber, A.4    Schirmacher, P.5    Stenzinger, A.6    Weichert, W.7
  • 24
    • 84867301515 scopus 로고    scopus 로고
    • Predicting the Functional Effect of Amino Acid Substitutions and Indels
    • Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the Functional Effect of Amino Acid Substitutions and Indels. PLoS ONE. 2012; 7: e46688.
    • (2012) PLoS ONE. , vol.7
    • Choi, Y.1    Sims, G.E.2    Murphy, S.3    Miller, J.R.4    Chan, A.P.5
  • 25
    • 68149165614 scopus 로고    scopus 로고
    • Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
    • Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc, 2009; 4: 1073-81.
    • (2009) Nat Protoc , vol.4 , pp. 1073-1081
    • Kumar, P.1    Henikoff, S.2    Ng, P.C.3
  • 26
    • 77955151784 scopus 로고    scopus 로고
    • MutationTaster evaluates disease-causing potential of sequence alterations
    • Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2012; 7:575-6.
    • (2012) Nat Methods. , vol.7 , pp. 575-576
    • Schwarz, J.M.1    Rödelsperger, C.2    Schuelke, M.3    Seelow, D.4
  • 27
    • 0036713510 scopus 로고    scopus 로고
    • Human non-synonymous SNPs: server and survey
    • Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res, 2002; 30: 3894-900.
    • (2002) Nucleic Acids Res , vol.30 , pp. 3894-3900
    • Ramensky, V.1    Bork, P.2    Sunyaev, S.3
  • 30
    • 84891083559 scopus 로고    scopus 로고
    • The biology and clinical impact of genetic lesions in myeloid malignancies
    • Lindsley RC, Ebert BL. The biology and clinical impact of genetic lesions in myeloid malignancies. Blood. 2013; 122: 3741-8.
    • (2013) Blood. , vol.122 , pp. 3741-3748
    • Lindsley, R.C.1    Ebert, B.L.2
  • 31
    • 84880450809 scopus 로고    scopus 로고
    • Leveraging cancer genome information in hematologic malignancies
    • Rampal R, Levine RL. Leveraging cancer genome information in hematologic malignancies. J Clin Oncol. 2013; 31: 1885-92.
    • (2013) J Clin Oncol. , vol.31 , pp. 1885-1892
    • Rampal, R.1    Levine, R.L.2
  • 34
    • 0037103190 scopus 로고    scopus 로고
    • ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma
    • Grønbaek K, Worm J, Ralfkiaer E, Ahrenkiel V, Hokland P, Guldberg P. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. Blood. 2002; 100: 1430-7
    • (2002) Blood , vol.100 , pp. 1430-1437
    • Grønbaek, K.1    Worm, J.2    Ralfkiaer, E.3    Ahrenkiel, V.4    Hokland, P.5    Guldberg, P.6
  • 36
    • 16544377649 scopus 로고    scopus 로고
    • Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection.
    • Zuniga EI, McGavern DB, Pruneda-Paz JL, Teng C, Oldstone MB. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat Immunol. 2004; 5: 1227-1234
    • (2004) Nat Immunol. , vol.5 , pp. 1227-1234
    • Zuniga, E.I.1    McGavern, D.B.2    Pruneda-Paz, J.L.3    Teng, C.4    Oldstone, M.B.5
  • 40
    • 84868569000 scopus 로고    scopus 로고
    • Targeting oncogenic Ras signaling in hematologic malignancies
    • Ward AF, Braun BS, Shannon KM. Targeting oncogenic Ras signaling in hematologic malignancies. Blood. 2012; 120: 3397-406.
    • (2012) Blood. , vol.120 , pp. 3397-3406
    • Ward, A.F.1    Braun, B.S.2    Shannon, K.M.3
  • 42
    • 34248591612 scopus 로고    scopus 로고
    • Targeting the Raf-MEK-ERK mitogenactivated protein kinase cascade for the treatment of cance
    • Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogenactivated protein kinase cascade for the treatment of cance. Oncogene. 2007; 26:3291-310.
    • (2007) Oncogene. , vol.26 , pp. 3291-3310
    • Roberts, P.J.1    Der, C.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.